SCHEMBL6896965

SCHEMBL6896965

CCCCOc1ccc(N(C)C(=O)CC2(O)CCN(Cc3ccccc3)CC2)cc1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
MMP1 P03956 2/20 0.42
MMP9 P14780 2/20 0.42
MMP13 P45452 2/20 0.42
ADAM17 P78536 1/20 0.42
CHRM2 P08172 2/20 0.42
CHRM1 P11229 1/20 0.42
CHRM3 P20309 1/20 0.40
SSTR5 P35346 2/20 0.40
PKM P14618 1/20 0.39
MAPK1 P28482 1/20 0.39
MAPT P10636 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
ABL1 P00519 1/20 0.39
RIN1 Q13671 1/20 0.39
OPRM1 P35372 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6783453 0.87 MEN1 (0.41) MEN1KMT2AMMP1MMP9MMP13
SCHEMBL6790359 0.87 PTPN1 (0.44) MEN1KMT2AMMP1MMP9MMP13
SCHEMBL6784170 0.86 KMT2A (0.54) MEN1KMT2AMMP1MMP9MMP13
SCHEMBL6901175 0.85 KMT2A (0.48) MEN1KMT2AMMP1MMP9MMP13
SCHEMBL6786307 0.84 CHRM2 (0.43) MEN1KMT2AMMP1MMP9MMP13
SCHEMBL6782616 0.83 KMT2A (0.46) MEN1KMT2AMMP1MMP9MMP13
SCHEMBL6785840 0.83 KMT2A (0.47) MEN1KMT2AMMP1MMP9MMP13
Hydrochloric Acid SCHEMBL6785001 0.83 CHRM2 (0.42) MEN1KMT2AMMP1MMP9MMP13
SCHEMBL6783406 0.81 PKM (0.56) MEN1KMT2AMMP1MMP9MMP13
SCHEMBL6789155 0.78 DRD4 (0.47) MEN1KMT2AMMP1MMP9MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6710060-B2 4-hydroxypiperidine derivatives having antiarrhythmic activity MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2004-03-23 US disclosed
US-20020188006-A1 4-hydroxypiperidine derivatives having antiarrhythmic activity MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2002-12-12 US disclosed
EP-1182192-A1 4-HYDROXYPIPERIDINE DERIVATIVES HAVING ANTIARRHYTHMIC EFFECT MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2002-02-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020188006-A1 4-hydroxypiperidine derivatives having antiarrhythmic activity SCN5A, RYR2, SCN1B MEN1 4123/4885KMT2A 2156/4885MMP1 1180/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.